Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | methionyl-tRNA synthetase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.016 | 1 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.016 | 1 | 1 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.016 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.016 | 1 | 0.5 |
Giardia lamblia | Kinase, CMGC GSK | 0.016 | 1 | 0.5 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.016 | 1 | 0.5 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.016 | 1 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.016 | 1 | 0.5 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.016 | 1 | 1 |
Echinococcus multilocularis | protein kinase shaggy | 0.016 | 1 | 1 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.016 | 1 | 0.5 |
Loa Loa (eye worm) | multisynthetase complex auxiliary component p43 | 0.0107 | 0.5754 | 0.012 |
Entamoeba histolytica | protein kinase domain containing protein | 0.016 | 1 | 1 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.016 | 1 | 0.5 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.016 | 1 | 1 |
Onchocerca volvulus | 0.016 | 1 | 0.5 | |
Trichomonas vaginalis | CMGC family protein kinase | 0.016 | 1 | 0.5 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.016 | 1 | 1 |
Giardia lamblia | Kinase, CMGC GSK | 0.016 | 1 | 0.5 |
Chlamydia trachomatis | methionine--tRNA ligase | 0.0106 | 0.5702 | 0.5 |
Echinococcus granulosus | protein kinase shaggy | 0.016 | 1 | 1 |
Treponema pallidum | methionyl-tRNA synthetase | 0.0124 | 0.7098 | 0.5 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.016 | 1 | 0.5 |
Entamoeba histolytica | protein kinase domain containing protein | 0.016 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 4 nM | Compound tested for inhibition of Staphylococcus aureus MRS (methionyl tRNA synthetase) in aminoacylation assay | ChEMBL. | 12639554 |
IC50 (binding) | = 4 nM | Compound tested for inhibition of Staphylococcus aureus MRS (methionyl tRNA synthetase) in aminoacylation assay | ChEMBL. | 12639554 |
MIC (functional) | = 0.25 ug ml-1 | In vitro Antibacterial activity of compound against Enterococcus faecalis 1 | ChEMBL. | 12639554 |
MIC (functional) | = 0.5 ug ml-1 | In vitro Antibacterial activity of compound against Staphylococcus aureus Oxford | ChEMBL. | 12639554 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.